Notice of Registration - 2010
FR Doc 2010-18495[Federal Register: July 28, 2010 (Volume 75, Number 144)]
[Notices]
[Page 44286]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr28jy10-117]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated March 16, 2010, and published in the Federal
Register on March 24, 2010, (75 FR 14190), Sigma Aldrich Research
Biochemicals, Inc., 1-3 Strathmore Road, Natick, Massachusetts 01760-
2447, made application by renewal to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of the
basic classes of controlled substances listed in schedules I and II:
| Drug |
Schedule |
| Cathinone (1235) |
I |
| Methcathinone (1237) |
I |
| Aminorex (1585) |
I |
| Alpha-ethyltryptamine (7249) |
I |
| Lysergic acid diethylamide (7315) |
I |
| Tetrahydrocannabinols (7370) |
I |
| 4-Bromo-2,5-dimethoxyamphetamine (7391) |
I |
| 4-Bromo-2,5-dimethoxyphenethylamine (7392) |
I |
| 2,5-Dimethoxyamphetamine (7396) |
I |
| 3,4-Methylenedioxyamphetamine (7400) |
I |
| N-Hydroxy-3,4-methylenedioxyamphetamine (7402) |
I |
| 3,4-Methylenedioxy-N-ethylamphetamine (7404) |
I |
| 3,4-Methylenedioxymethamphetamine (MDMA) (7405) |
I |
| Psilocybin (7437) |
I |
| 5-Methoxy-N,N-diisopropyltryptamine (7439) |
I |
| 1-[1-(2-Thienyl)cyclohexyl]piperidine (TCP) (7470) |
I |
| N-Benzylpiperazine (BZP) (7493) |
I |
| Heroin (9200) |
I |
| Normorphine (9313) |
I |
| Amphetamine (1100) |
II |
| Methamphetamine (1105) |
II |
| Nabilone (7379) |
II |
| 1-Phenylcyclohexylamine (7460) |
II |
| Phencyclidine (7471) |
II |
| Cocaine (9041) |
II |
| Codeine (9050) |
II |
| Diprenorphine (9058) |
II |
| Ecgonine (9180) |
II |
| Levomethorphan (9210) |
II |
| Levorphanol (9220) |
II |
| Meperidine (9230) |
II |
| Metazocine (9240) |
II |
| Methadone (9250) |
II |
| Morphine (9300) |
II |
| Thebaine (9333) |
II |
| Levo-alphacetylmethadol (9648) |
II |
| Remifentanil (9739) |
II |
| Carfentanil (9743) |
II |
| Fentanyl (9801) |
II |
The company plans to manufacture reference standards.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Sigma Aldrich Research Biochemicals, Inc., to manufacture the listed
basic classes of controlled substances is consistent with the public
interest at this time. DEA has investigated Sigma Aldrich Research
Biochemicals, Inc., to ensure that the company's registration is
consistent with the public interest. The investigation has included
inspection and testing of the company's physical security systems,
verification of the company's compliance with state and local laws, and
a review of the company's background and history. Therefore, pursuant
to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above
named company is granted registration as a bulk manufacturer of the
basic classes of controlled substances listed.
Dated: July 19, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2010-18495 Filed 7-27-10; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |
